Inflammation, anti-inflammatory agents, and the role of colchicine in carotid artery stenosis.
Autor: | Chlorogiannis DD; Department of D/I Radiology, Patras General Hospital, Patras, Greece., Pargaonkar S; Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York Ciry, NY, USA., Papanagiotou P; First Department of Radiology, School of Medicine, National & Kapodistrian University of Athens, Areteion Hospital, Athens, Greece.; Department of Diagnostic and Interventional Neuroradiology, Hospital Bremen-Mitte/Bremen-Ost, Bremen, Germany., Bakogiannis NC; Division of Vascular Surgery, Laiko General Hospital/University of Athens School of Medicine, Athens, Greece., Bakoyiannis C; Division of Vascular Surgery, Laiko General Hospital/University of Athens School of Medicine, Athens, Greece., Kokkinidis DG; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | VASA. Zeitschrift fur Gefasskrankheiten [Vasa] 2024 Jan; Vol. 53 (1), pp. 4-12. Date of Electronic Publication: 2023 Dec 11. |
DOI: | 10.1024/0301-1526/a001104 |
Abstrakt: | Cardiovascular disease is a major cause of morbidity and mortality worldwide. In the last few years, the role of inflammation and inflammatory modulatory medications is investigated for the optimal treatment of coronary artery disease. It can be hypothesized that since inflammation is also involved in carotid artery stenosis development and progression, the same class of medication could be useful. Our objective with this review is to present the available evidence, published studies and promising ongoing trials on the role of anti-inflammatory medications - with a special emphasis on the most commonly used drug of this class: colchicine - in patients with carotid artery stenosis. |
Databáze: | MEDLINE |
Externí odkaz: |